Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Health Economics|February 28, 2006
Using rank data to estimate health state utility modelsChristopher McCabe, John Brazier, Peter Gilks, et al.Pharmaceutical Statistics|April 3, 2009
The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulationRichard M Nixon, Anthony O'Hagan, Jeremy Oakley, et al.BMJ (Clinical Research Ed.)|March 8, 2003
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosisJim Chilcott, Chris McCabe, Paul Tappenden, et al.Pharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.Pharmacoeconomics|October 5, 2011
Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancerRobert I Griffiths, Richard L Barron, Michelle L Gleeson, et al.Pharmaceutical Statistics|April 4, 2022
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case studyBjörn Holzhauer, Lisa V Hampson, John Paul Gosling, et al.BMC Neurology|January 8, 2009
The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureMark Pickin, Cindy L Cooper, Timothy Chater, et al.Journal of Official Statistics|March 8, 2016
Letter to the Editor: Probabilistic population forecasts for informed decision makingJakub Bijak, Isabel Alberts, Juha Alho, et al.Pageof 3